FDA approves Mekinist in combination with Tafinlar for advanced melanoma
PRESS RELEASE This week the U.S. Food and Drug Administration approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed More...